"Long-term use of a common breast cancer drug may hike the risk of developing a deadly second tumour, a study suggests.And with time, more probs related to diet pills will come to light, too.
Tamoxifen, given to thousands of British women, prevents tumours being fuelled by the sex hormone oestrogen, and stops them returning after surgery.
But a US study links use of the drug to a four-fold raised risk of developing a more aggressive, difficult-to-treat tumour, not dependent on oestrogen."
Fitness Watch is your site for making sense of fitness advice.
"Truth" has a shelf life.
The shelf life of "truth" is very short in the domains of fitness, health and well-being.
The reason is that so much of what we are told is "true" is really baseless.
At Fitness Watch we separate fitness information from fitness noise.
Thursday, August 27, 2009
Tamoxifen link to second tumours
Oops.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.